BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$255B |
| 2 |
Thermo Fisher Scientific
TMO
|
+$458M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$288M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$199M |
| 5 |
Advanced Micro Devices
AMD
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$622M |
| 2 |
Microsoft
MSFT
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$533M |
| 4 |
Amazon
AMZN
|
+$353M |
| 5 |
Diageo
DEO
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.41% |
| 2 | Financials | 6.24% |
| 3 | Healthcare | 5.83% |
| 4 | Consumer Discretionary | 5.56% |
| 5 | Industrials | 3.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Syndax Pharmaceuticals
SNDX
$1.77B
| $1.59M | ﹤0.01% |
66,277
+53,665
| +426% | +$1.2M |
|
1902
Brookfield
BN
$110B
| $1.59M | ﹤0.01% |
72,121
+70,160
| +3,578% | +$1.82M |
|
|
PAQC
1903
DELISTED
Provident Acquisition Corp. Class A Ordinary Shares
PAQC
| $1.59M | ﹤0.01% |
+158,970
| New | +$1.58M |
|
1904
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $1.59M | ﹤0.01% |
200
-139
| -41% | -$11.7K |
|
1905
LivaNova
LIVN
$4.53B
| $1.59M | ﹤0.01% |
31,227
+12,503
| +67% | +$742K |
|
|
CDMO
1906
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.58M | ﹤0.01% |
82,715
-24,748
| -23% | -$451K |
|
1907
Philips
PHG
$26.2B
| $1.58M | ﹤0.01% |
119,623
+101,340
| +554% | +$1.65M |
|
1908
CALL
Yum China
YUMC
$16.4B
| $1.58M | ﹤0.01% |
333
| – | – |
|
1909
PUT
Keysight
KEYS
$60.6B
| $1.57M | ﹤0.01% |
+100
| New | +$16K |
|
1910
Surgery Partners
SGRY
$2.01B
| $1.57M | ﹤0.01% |
67,148
+30,617
| +84% | +$978K |
|
1911
Patrick Industries
PATK
$2.79B
| $1.57M | ﹤0.01% |
53,657
+830
| +2% | +$30.2K |
|
1912
Valley National Bancorp
VLY
$8.25B
| $1.56M | ﹤0.01% |
144,877
-93,435
| -39% | -$1.08M |
|
1913
US Foods
USFD
$24B
| $1.56M | ﹤0.01% |
59,064
-831
| -1% | -$25.8K |
|
1914
Global X Lithium & Battery Tech ETF
LIT
$1.6B
| $1.56M | ﹤0.01% |
23,611
-6,503
| -22% | -$483K |
|
1915
Kura Oncology
KURA
$882M
| $1.56M | ﹤0.01% |
113,874
+99,739
| +706% | +$1.54M |
|
1916
IonQ
IONQ
$18.2B
| $1.55M | ﹤0.01% |
+306,538
| New | +$1.7M |
|
1917
Melco Resorts & Entertainment
MLCO
$2.14B
| $1.55M | ﹤0.01% |
234,162
+86,639
| +59% | +$478K |
|
1918
Innoviva
INVA
$1.5B
| $1.55M | ﹤0.01% |
133,546
+6,945
| +5% | +$95.2K |
|
|
B
1919
PUT
Barrick Mining
B
$67.3B
| $1.55M | ﹤0.01% |
1,000
| – | – |
|
1920
Worthington Enterprises
WOR
$2.78B
| $1.55M | ﹤0.01% |
65,913
-8,665
| -12% | -$265K |
|
|
RETA
1921
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.55M | ﹤0.01% |
61,650
-20,322
| -25% | -$563K |
|
1922
Bionano Genomics
BNGO
$13.8M
| $1.55M | ﹤0.01% |
1,410
-68
| -5% | -$89.8K |
|
|
AEL
1923
DELISTED
American Equity Investment Life Holding Company
AEL
| $1.55M | ﹤0.01% |
41,516
+13,502
| +48% | +$507K |
|
1924
Vanguard Total International Bond ETF
BNDX
$83B
| $1.54M | ﹤0.01% |
32,327
-2,256
| -7% | -$112K |
|
1925
Ardmore Shipping
ASC
$681M
| $1.54M | ﹤0.01% |
168,941
+153,733
| +1,011% | +$1.37M |
|
Similar funds
BNP Paribas Financial Markets's Q3 2022 Portfolio in Review
As of Q3 2022, BNP Paribas Financial Markets held 5,152 positions worth $62.5B, down 2.4% from $64.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
BNP Paribas Financial Markets deployed $254B of net new capital in Q3 2022, opening 1,204 new positions and adding to 1,887 existing holdings. Its largest new stake was Marvell Technology: 910,010 shares worth $39M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $622M trimmed.
- BNP Paribas Financial Markets's largest Q3 2022 buy was Marvell Technology: 910,010 shares worth $39M.
- BNP Paribas Financial Markets added most to Berkshire Hathaway Class A in Q3 2022, an estimated $255B increase.
- BNP Paribas Financial Markets's biggest Q3 2022 reduction was Apple, cutting an estimated $622M.
- BNP Paribas Financial Markets fully exited Alphabet (Google) Class A in Q3 2022, selling an estimated $533M.
- BNP Paribas Financial Markets's ten largest holdings make up 12% of its $62.5B portfolio in Q3 2022.
- BNP Paribas Financial Markets opened 1,204 new positions and closed 420 in Q3 2022.
- BNP Paribas Financial Markets's portfolio value fell 2.4% quarter-over-quarter to $62.5B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2022, filed 15 Nov 2022.